The FDA has released a new draft guidance: Internet/Social Media Platforms: Correcting Independent Third-Party Misinformation About Prescription Drugs and Medical Devices. This draft guidance is a welcome addition for the industry as it clearly shows how healthcare firms can improve the quality of information on the internet without being held responsible for it in perpetuity.
Inside the Klick POV:
- Summary of the guidance and what it means for healthcare marketers
- Clear descriptions about content for which the firm is not responsible
- Guidelines for responses that the FDA will consider exempt from promotional rules
- Some approaches to correcting information for marketers
- Recommendations on creating guidelines surrounding correcting information
This is one of two draft guidances that the FDA released yesterday. See also FDA draft guidance on ISI in space-limited channels.